Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
ALERTS, HOT STOCKS & CHARTS
Posted On: 08/15/2016 12:51:57 PM
Post# of 145211
Avatar
Posted By: BCNstocks
$ARTH .65! Huge clinical study news out today! Was at almost $1 last month!

Corporate Overview:

Bleeding and leakage remain compelling problems to solve. Patients matter.

The AC5 Surgical Hemostatic Device™ value proposition is based on the premise of faster and safer surgery. The product is designed to be simple (user-friendly), effective (works promptly), versatile (useful in challenging situations such as laparoscopic surgery**), and safe. These claims alongside the multipurpose nature of AC5™ distinguish it from first-generation solutions currently in use.

Large markets filled with problem products

In 2012, annual worldwide sales were over $2.8B for hemostatic agents and nearly $1.3B for fibrin and other sealants, which seal other leaks (cerebrospinal fluid, pleural, etc.). These products are anticipated to surpass global combined sales of over $7B in 2017.

Today's News: Clinical Safety and Performance of AC5 Successfully Demonstrated in Dermatology Procedure Performed on 46 Skin Lesion Patients With Bleeding Wounds

http://finance.yahoo.com/news/arch-therapeuti...00951.html

(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site